These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 38195762)
1. Mitofusin 1 silencing decreases the senescent associated secretory phenotype, promotes immune cell recruitment and delays melanoma tumor growth after chemotherapy. Tarallo D; Martínez J; Leyva A; Mónaco A; Perroni C; Tassano M; Gambini JP; Cappetta M; Durán R; Moreno M; Quijano C Sci Rep; 2024 Jan; 14(1):909. PubMed ID: 38195762 [TBL] [Abstract][Full Text] [Related]
2. Mitofusins modulate the increase in mitochondrial length, bioenergetics and secretory phenotype in therapy-induced senescent melanoma cells. Martínez J; Tarallo D; Martínez-Palma L; Victoria S; Bresque M; Rodríguez-Bottero S; Marmisolle I; Escande C; Cassina P; Casanova G; Bollati-Fogolín M; Agorio C; Moreno M; Quijano C Biochem J; 2019 Sep; 476(17):2463-2486. PubMed ID: 31431479 [TBL] [Abstract][Full Text] [Related]
3. Senescence-associated secretory factors induced by cisplatin in melanoma cells promote non-senescent melanoma cell growth through activation of the ERK1/2-RSK1 pathway. Sun X; Shi B; Zheng H; Min L; Yang J; Li X; Liao X; Huang W; Zhang M; Xu S; Zhu Z; Cui H; Liu X Cell Death Dis; 2018 Feb; 9(3):260. PubMed ID: 29449532 [TBL] [Abstract][Full Text] [Related]
4. IFN-γ and TNF Induce Senescence and a Distinct Senescence-Associated Secretory Phenotype in Melanoma. Homann L; Rentschler M; Brenner E; Böhm K; Röcken M; Wieder T Cells; 2022 Apr; 11(9):. PubMed ID: 35563820 [TBL] [Abstract][Full Text] [Related]
5. Zhang JW; Zhang D; Yin HS; Zhang H; Hong KQ; Yuan JP; Yu BP Gut Microbes; 2023; 15(1):2197836. PubMed ID: 37017266 [TBL] [Abstract][Full Text] [Related]
6. Dynamic and scalable assessment of the senescence-associated secretory phenotype (SASP). Malaquin N; Rodier F Methods Cell Biol; 2024; 181():181-195. PubMed ID: 38302239 [TBL] [Abstract][Full Text] [Related]
7. Release of mitochondrial dsRNA into the cytosol is a key driver of the inflammatory phenotype of senescent cells. López-Polo V; Maus M; Zacharioudakis E; Lafarga M; Attolini CS; Marques FDM; Kovatcheva M; Gavathiotis E; Serrano M Nat Commun; 2024 Aug; 15(1):7378. PubMed ID: 39191740 [TBL] [Abstract][Full Text] [Related]
8. SCAMP4 enhances the senescent cell secretome. Kim KM; Noh JH; Bodogai M; Martindale JL; Pandey PR; Yang X; Biragyn A; Abdelmohsen K; Gorospe M Genes Dev; 2018 Jul; 32(13-14):909-914. PubMed ID: 29967290 [TBL] [Abstract][Full Text] [Related]
9. Potential Regulators of the Senescence-Associated Secretory Phenotype During Senescence and Aging. Han X; Lei Q; Xie J; Liu H; Li J; Zhang X; Zhang T; Gou X J Gerontol A Biol Sci Med Sci; 2022 Nov; 77(11):2207-2218. PubMed ID: 35524726 [TBL] [Abstract][Full Text] [Related]
10. Chronic Resveratrol Treatment Inhibits MRC5 Fibroblast SASP-Related Protumoral Effects on Melanoma Cells. Menicacci B; Laurenzana A; Chillà A; Margheri F; Peppicelli S; Tanganelli E; Fibbi G; Giovannelli L; Del Rosso M; Mocali A J Gerontol A Biol Sci Med Sci; 2017 Sep; 72(9):1187-1195. PubMed ID: 28329136 [TBL] [Abstract][Full Text] [Related]
11. Targeting senescence-associated secretory phenotypes to remodel the tumour microenvironment and modulate tumour outcomes. Xiong J; Dong L; Lv Q; Yin Y; Zhao J; Ke Y; Wang S; Zhang W; Wu M Clin Transl Med; 2024 Sep; 14(9):e1772. PubMed ID: 39270064 [TBL] [Abstract][Full Text] [Related]
12. Isolation methodology is essential to the evaluation of the extracellular vesicle component of the senescence-associated secretory phenotype. Wallis R; Josipovic N; Mizen H; Robles-Tenorio A; Tyler EJ; Papantonis A; Bishop CL J Extracell Vesicles; 2021 Feb; 10(4):e12041. PubMed ID: 33659050 [TBL] [Abstract][Full Text] [Related]
13. Reshaping of the tumor microenvironment by cellular senescence: An opportunity for senotherapies. D'Ambrosio M; Gil J Dev Cell; 2023 Jun; 58(12):1007-1021. PubMed ID: 37339603 [TBL] [Abstract][Full Text] [Related]
14. Overcoming the senescence-associated secretory phenotype (SASP): a complex mechanism of resistance in the treatment of cancer. Chambers CR; Ritchie S; Pereira BA; Timpson P Mol Oncol; 2021 Dec; 15(12):3242-3255. PubMed ID: 34137158 [TBL] [Abstract][Full Text] [Related]
16. The role of cellular senescence and SASP in tumour microenvironment. Takasugi M; Yoshida Y; Hara E; Ohtani N FEBS J; 2023 Mar; 290(5):1348-1361. PubMed ID: 35106956 [TBL] [Abstract][Full Text] [Related]
17. KDM4 Orchestrates Epigenomic Remodeling of Senescent Cells and Potentiates the Senescence-Associated Secretory Phenotype. Zhang B; Long Q; Wu S; Xu Q; Song S; Han L; Qian M; Ren X; Liu H; Jiang J; Guo J; Zhang X; Chang X; Fu Q; Lam EW; Campisi J; Kirkland JL; Sun Y Nat Aging; 2021 May; 1(5):454-472. PubMed ID: 34263179 [TBL] [Abstract][Full Text] [Related]
18. Role of Clusterin/NF-κB in the secretion of senescence-associated secretory phenotype in Cr(VI)-induced premature senescent L-02 hepatocytes. Liang Y; Liang N; Ma Y; Tang S; Ye S; Xiao F Ecotoxicol Environ Saf; 2021 Aug; 219():112343. PubMed ID: 34020271 [TBL] [Abstract][Full Text] [Related]
19. Keeping the senescence secretome under control: Molecular reins on the senescence-associated secretory phenotype. Malaquin N; Martinez A; Rodier F Exp Gerontol; 2016 Sep; 82():39-49. PubMed ID: 27235851 [TBL] [Abstract][Full Text] [Related]
20. Targeting senescent cells to reshape the tumor microenvironment and improve anticancer efficacy. Jiang B; Zhang W; Zhang X; Sun Y Semin Cancer Biol; 2024 Jun; 101():58-73. PubMed ID: 38810814 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]